- Type / Class
- Equity / Common Stock
- Shares outstanding
- 80,855,533
- Total 13F shares
- 92,672,768
- Share change
- +9,238,795
- Total reported value
- $7,039,705,885
- Put/Call ratio
- 74%
- Price per share
- $75.96
- Number of holders
- 346
- Value change
- +$724,070,224
- Number of buys
- 207
- Number of sells
- 133
Quarterly Holders Quick Answers
What is CUSIP 69366J200?
CUSIP 69366J200 identifies PTCT - PTC THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 69366J200:
Top shareholders of PTCT - PTC THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
|
Company |
15%
|
11,904,696
|
$892,256,965 | +$421,991,884 | 30 Nov 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
8,288,999
|
$508,695,869 | — | 30 Sep 2025 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
9.6%
|
7,746,415
|
$475,397,489 | — | 30 Sep 2025 | |
| JANUS HENDERSON GROUP PLC |
13D/G
13F
|
Company |
6%
|
4,851,332
|
$376,123,770 | $0 | 31 Dec 2025 | |
| STATE STREET CORP |
13D/G
13F
|
STATE STREET CORPORATION · Company |
5.2%
|
4,206,126
|
$326,100,949 | $0 | 31 Dec 2025 | |
| TORONTO DOMINION BANK |
13D/G
13F
|
The Toronto-Dominion Bank · Company |
5.2%
|
4,138,215
|
$320,835,809 | $0 | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
13D/G
|
Company |
4.8%
from 13D/G
|
4,918,619
|
$301,855,649 | — | 30 Sep 2025 | |
| ARMISTICE CAPITAL, LLC |
13D/G
13F
|
Company |
6.9%
|
5,434,843
|
$269,133,425 | -$46,705,135 | 31 Mar 2025 | |
| Camber Capital Management LP |
13D/G
|
— |
4.2%
|
3,200,000
|
$158,464,000 | $0 | 31 Dec 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2.7%
|
2,174,608
|
$133,455,693 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
1,950,878
|
$119,742,808 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.1%
|
1,731,025
|
$106,233,004 | — | 30 Sep 2025 | |
| FMR LLC |
13F
|
Company |
2%
|
1,611,775
|
$98,914,644 | — | 30 Sep 2025 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
2%
|
1,584,678
|
$97,251,689 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.9%
|
1,517,036
|
$93,100,498 | — | 30 Sep 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.9%
|
1,500,000
|
$92,055,000 | — | 30 Sep 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.7%
|
1,407,974
|
$86,214,711 | — | 30 Sep 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.5%
|
1,220,642
|
$74,910,798 | — | 30 Sep 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.4%
|
1,157,034
|
$71,007,177 | — | 30 Sep 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.4%
|
1,131,749
|
$69,455,436 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.3%
|
1,056,481
|
$64,836,239 | — | 30 Sep 2025 | |
| Hood River Capital Management LLC |
13F
|
Company |
1.2%
|
995,782
|
$61,111,141 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.1%
|
927,300
|
$56,908,401 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.1%
|
876,409
|
$53,785,221 | — | 30 Sep 2025 | |
| Palo Alto Investors LP |
13F
|
Company |
1.1%
|
862,613
|
$52,938,560 | — | 30 Sep 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.99%
|
800,878
|
$49,150,000 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.96%
|
773,178
|
$47,448,279 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.91%
|
737,569
|
$45,264,610 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.89%
|
721,202
|
$44,260,167 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.87%
|
702,758
|
$43,128,258 | — | 30 Sep 2025 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.62%
|
503,966
|
$30,928,393 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.61%
|
490,934
|
$30,128,620 | — | 30 Sep 2025 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.59%
|
473,758
|
$29,074,528 | — | 30 Sep 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.57%
|
458,330
|
$28,129,000 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.56%
|
452,209
|
$27,752,066 | — | 30 Sep 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
0.54%
|
438,477
|
$26,909,333 | — | 30 Sep 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.53%
|
430,934
|
$26,446,420 | — | 30 Sep 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.53%
|
424,999
|
$26,082,189 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.52%
|
419,417
|
$25,739,700 | — | 30 Sep 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.47%
|
378,053
|
$23,201,000 | — | 30 Sep 2025 | |
| Boston Partners |
13F
|
Company |
0.45%
|
361,664
|
$22,196,952 | — | 30 Sep 2025 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.43%
|
348,366
|
$21,379,221 | — | 30 Sep 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.41%
|
331,256
|
$20,329,181 | — | 30 Sep 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.4%
|
323,548
|
$19,856,141 | — | 30 Sep 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.39%
|
313,057
|
$19,212,308 | — | 30 Sep 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.36%
|
291,000
|
$17,858,670 | — | 30 Sep 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.36%
|
288,767
|
$17,721,631 | — | 30 Sep 2025 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.35%
|
284,891
|
$17,483,761 | — | 30 Sep 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.35%
|
280,551
|
$17,217,414 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.34%
|
273,076
|
$16,758,663 | — | 30 Sep 2025 |
Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q4 2025
As of 31 Dec 2025,
PTC THERAPEUTICS, INC. - Common Stock (PTCT) was held by
346 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
92,672,768 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, RTW INVESTMENTS, LP, JANUS HENDERSON GROUP PLC, STATE STREET CORP, TORONTO DOMINION BANK, WELLINGTON MANAGEMENT GROUP LLP, ARMISTICE CAPITAL, LLC, GEODE CAPITAL MANAGEMENT, LLC, and D. E. Shaw & Co., Inc..
This page lists
346
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
290
Q4 2025 holders
346
Holder diff
56
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.